RxDoctor Payments DataLook up a doctor →

Chelsea Collins

Adult Health · Nashville, TNNPI 1952837932

Payments from drug & device makers

$7,247in general payments, 2019–2025

Across 293 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$702
  • Novartis$500
  • Johnson & Johnson$497
  • Bristol Myers Squibb$411
  • Seagen Inc.$315
  • AbbVie$305
  • plus $5K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)22$702
Novartis20$500
Johnson & Johnson(2 entities)16$497
Bristol Myers Squibb22$411
Seagen Inc.12$315
AbbVie13$305
Amgen11$287
Eisai Inc.10$256
Daiichi Sankyo Inc.10$242
Sanofi8$240
Regeneron Healthcare Solutions, Inc.7$231
Takeda Pharmaceuticals U.S.A., Inc.7$219
Incyte Corporation8$199
Lilly USA, LLC5$196
Merck7$188
E.r. Squibb & Sons, L.L.C.9$166
Bayer8$161
Tersera Therapeutics LLC8$154
AVEO Pharmaceuticals, Inc.4$152
Genentech USA, Inc.7$127
Gilead5$106
Beigene USA, Inc.4$82
Pfizer4$78
Puma Biotechnology, Inc.4$77
Genmab U.S., Inc.3$75
Servier Pharmaceuticals LLC3$70
Exelixis Inc.3$67
Rigel Pharmaceuticals, Inc.3$67
Jazz Pharmaceuticals Inc.3$64
GSK3$59
Mirati Therapeutics, Inc.3$58
EMD Serono, Inc.3$57
Stemline Therapeutics Inc.3$53
Iovance Biotherapeutics, Inc.2$51
Sun Pharmaceutical Industries Inc.2$49
Sobi, Inc2$47
Pharmacyclics LLC, An Abbvie Company2$45
Blueprint Medicines Corporation1$45
Deciphera Pharmaceuticals Inc.2$41
Morphosys, US Inc.2$39
Array Biopharma Inc2$38
Legend Biotech USA Inc.1$37
ADC Therapeutics America, Inc.2$36
Optos, Inc.1$36
Pharmacosmos Therapeutics Inc.2$35
Sumitomo Pharma America, Inc.2$33
Taiho Oncology, Inc.1$26
Pharmaessentia USA Corporation1$26
Geron Corporation1$24
Dova Pharmaceuticals1$24
Boehringer Ingelheim1$22
Shield Therapeutics Inc1$22
Cycle Pharmaceuticals Inc1$22
Coherus Oncology, Inc.1$22
Karyopharm Therapeutics Inc.1$21
G1 Therapeutics, Inc.1$18
Myovant Sciences Inc.1$16
Astellas Pharma US Inc1$11

How this compares

$7,247 in reported general payments places this provider in the 90th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$4,726
Medicare patients
16
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →